相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus
Julius Lindblom et al.
FRONTIERS IN MEDICINE (2022)
Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature
Alvaro Gomez et al.
AUTOIMMUNITY REVIEWS (2022)
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus
Alvaro Gomez et al.
RHEUMATOLOGY (2021)
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE
Alexander Borg et al.
RHEUMATOLOGY (2021)
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
Alvaro Gomez et al.
FRONTIERS IN MEDICINE (2021)
The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis
M. Gu et al.
LUPUS (2019)
Fatigue in systemic lupus: the role of disease activity and its correlates
D. R. Azizoddin et al.
LUPUS (2019)
The High Costs of Low-Grade Inflammation: Persistent Fatigue as a Consequence of Reduced Cellular-Energy Availability and Non-adaptive Energy Expenditure
Tamara E. Lacourt et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life
R. L. Kolotkin et al.
CLINICAL OBESITY (2017)
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
Milad Karimi et al.
PHARMACOECONOMICS (2016)
Systemic lupus erythematosus
Arvind Kaul et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus
R. Mina et al.
LUPUS (2015)
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
Vibeke Strand et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus
Li-Wei Zhu et al.
CLINICAL RHEUMATOLOGY (2010)
Psychometric Properties of the EuroQol-5D and Short Form-6D in Patients with Systemic Lupus Erythematosus
Rohit Aggarwal et al.
JOURNAL OF RHEUMATOLOGY (2009)
Quality of life in systemic lupus erythematosus
Pantelis Panopalis et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2006)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus
A Oeser et al.
ARTHRITIS AND RHEUMATISM (2005)
Circulating mononuclear cells in the obese are in a proinflammatory state
H Ghanim et al.
CIRCULATION (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The relationship between health-related quality of life and weight loss
RL Kolotkin et al.
OBESITY RESEARCH (2001)
Endpoints: consensus recommendations from OMERACT IV
V Strand et al.
LUPUS (2000)